News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Pearson J. Michael
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/05/2016 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.
Txns:
| Paid exercise price by delivering 14,412 options to buy
@ $73.77, valued at
$1.1M
|
|
11/09/2015 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.
Txns:
| Sold 147,054 shares
@ $74.67, valued at
$11M
Sold 800,345 shares
@ $76.66, valued at
$61.4M
Sold 350,000 shares
@ $84.26, valued at
$29.5M
|
|
03/02/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/09/2015 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.
Txns:
| Granted 450,000 options to buy
@ $0 |
|
03/13/2014 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.
Txns:
| Granted 502,996 options to buy
@ $0 |
|
12/17/2013 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.
Txns:
| Bought 184,247 shares
@ $81.41, valued at
$15M
|
|
12/19/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/26/2012 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.
Txns:
| Paid exercise price by delivering 25,787 shares
@ $0 |
|
04/26/2012 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.
Txns:
| Paid exercise price by delivering 101,877 shares
@ $0 |
|
04/16/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/28/2011 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.
Txns:
| Paid exercise price by delivering 50,997 shares
@ $0 |
|
10/26/2011 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.
Txns:
| Granted 155,642 shares
@ $0 |
|
10/03/2011 |
4
| Pearson J. Michael (Chairman of the Board and CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.
Txns:
| Granted 120,000 options to buy
@ $0 Granted 500,000 options to buy
@ $54.76, valued at
$27.4M
|
|
08/15/2011 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.
Txns:
| Bought 155,642 shares
@ $38.6192, valued at
$6M
|
|
04/26/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/14/2011 |
4
| Pearson J. Michael (CEO) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.
Txns:
| Disposed/sold 929,364 shares
@ $39.5, valued at
$36.7M
|
|
10/20/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/06/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/30/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/29/2010 |
3
| Pearson J. Michael (CEO) has filed a Form 3 on Valeant Pharmaceuticals International, Inc. |
02/03/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/08/2009 |
4
| Pearson J. Michael (CEO and Chairman of the Board) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL
Txns:
| Paid exercise price by delivering 188,875 shares
@ $31.93, valued at
$6M
|
|
12/03/2009 |
4
| Pearson J. Michael (CEO and Chairman of the Board) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL
Txns:
| Granted 200,481 options to buy
@ $0 Granted 173,750 options to buy
@ $0 Granted 500,000 options to buy
@ $37.41, valued at
$18.7M
|
|
07/27/2009 |
4
| Pearson J. Michael (CEO and Chairman of the Board) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL |
05/08/2009 |
4
| Pearson J. Michael (CEO and Chairman of the Board) has filed a Form 4 on VALEANT PHARMACEUTICALS INTERNATIONAL |
|
|